BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Defense
Grant: CA180190
Myeloma Crowd Research Initiative Award
Grant: n/a
National Cancer Institute
Grant: 1R01CA236814-01A1,3R01-CA236814-03S1,U54CA272691-01
NCI NIH HHS
Grant: R01 CA236814
NCI NIH HHS
Grant: R42 CA180190
NCI NIH HHS
Grant: U54 CA272691
NCI NIH HHS
Grant: R41 CA180190
National Institutes of Health
Grant: 1R01CA236814-01A1
Novel NEK2 signaling pathways in myeloma progression
FWCI
0.81
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals